Repeating an endoscopy with biopsy to test for Helicobacter pylori infection after a previous negative result is relatively common but may not provide much benefit, a Cleveland Clinic study suggests.Read More
A patient with macrolide-resistant nontuberculous mycobacterial (NTM) infection improves after lingulectomy.
Cleveland Clinic researchers have performed the first comprehensive immunoprofiling study of patients with severe fever with thrombocytopenia syndrome (SFTS), an emerging tick-borne disease.
It’s not yet clear whether IgG serology is reliable for evaluating infectivity and clinical immunity to COVID-19 reinfection, but patients will likely keep asking. Here’s some background to inform your response.
While the cause of death may seem obvious in individuals who test positive for SARS-CoV-2 and die after a febrile illness that evolves into respiratory failure, not all cases fit this stereotype.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A prototype blood-based screening test evaluated by Cleveland Clinic researchers and others can accurately detect and localize multiple types of cancer, often before symptoms show. The promising results raise hopes that the assay will help achieve the long-sought goal of population-scale early detection of cancer.
Cleveland Clinic Cancer Center investigators have published a body of research that may herald an era of improved staging and risk stratification for patients with Merkel cell carcinoma, utilizing distinct histologic patterns in sentinel lymph node biopsies.
Learn more about how COVID-19 causes ARDS, the histology of ARDS, and how diffuse alveolar damage causes hypoxia in this video.
A new study challenges existing guidelines for staging melanomas of the lower genital tract. In this article, the researchers discuss the similarities found in the molecular structure and survival outcomes of vulvar and vaginal melanomas.
In December 2019 Lisa Yerian, MD, became Cleveland Clinic’s first Chief Improvement Officer. Learn how Dr. Yerian helped the health system develop its own improvement model and how she applies continuous improvement tools in her personal life too.
This is one of the first case series in the world to examine lung biopsies from patients with vaping-associated lung illnesses.